The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Elbert Huang and Wen Wan.
Connection Strength

4.750
  1. Comparison of two propensity score-based methods for balancing covariates: the overlap weighting and fine stratification methods in real-world claims data. BMC Med Res Methodol. 2024 Jun 03; 24(1):122.
    View in: PubMed
    Score: 0.976
  2. The Economic Evaluation of Team Clinic-Group Approach to a Care Model of Early Adolescents With Type 1 Diabetes. J Pediatr Health Care. 2022 Sep-Oct; 36(5):430-437.
    View in: PubMed
    Score: 0.856
  3. Cost-effectiveness of Shared Telemedicine Appointments in Young Adults With T1D: CoYoT1 Trial. Diabetes Care. 2019 08; 42(8):1589-1592.
    View in: PubMed
    Score: 0.691
  4. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Med Decis Making. 2018 11; 38(8):942-953.
    View in: PubMed
    Score: 0.663
  5. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care. 2018 06; 41(6):1227-1234.
    View in: PubMed
    Score: 0.638
  6. A nurse driven care management program to engage older diabetes patients in personalized goal setting and disease management. Health Sci Rep. 2024 Jun; 7(6):e2208.
    View in: PubMed
    Score: 0.245
  7. Costs and Health Care Utilization Analysis of Medical Group Visits for Adults With Type 2 Diabetes in Community Health Centers. Med Care. 2023 12 01; 61(12):866-871.
    View in: PubMed
    Score: 0.233
  8. Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults. MDM Policy Pract. 2023 Jul-Dec; 8(2):23814683231187566.
    View in: PubMed
    Score: 0.230
  9. Effectiveness of Multilevel and Multidomain Interventions to Improve Glycemic Control in U.S. Racial and Ethnic Minority Populations: A Systematic Review and Meta-analysis. Diabetes Care. 2024 Sep 01; 47(9):1704-1712.
    View in: PubMed
    Score: 0.062
  10. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
    View in: PubMed
    Score: 0.054
  11. Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. J Gen Intern Med. 2022 02; 37(2):439-448.
    View in: PubMed
    Score: 0.051
  12. The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.